QL706

· Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QL706, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer